Nivolumab/Paclitaxel Combo Shows Antitumor Activity in EBV-Related, MSI-H, PD-L1+ Advanced Gastric Cancer
Opdivo combined with paclitaxel showed anti-tumor activity in a phase 1/2 study of gastric cancer patients with a variety of tumor markers,... Read More
Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
A study found that patients with gastroesophageal junction cancer who were treated with surgery and chemoradiotherapy had significantly longer disease-free survival if... Read More
Bemarituzumab Improves Gastric Cancer Survival Response Rates
In a study presented at ASCO GI, adding Five Prime’s experimental targeted drug to a modified FOLFOX chemotherapy regimen significantly improved survival... Read More
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
A study found that “cytoreductive” surgery combined with intraperitoneal chemotherapy improved survival for some gastric cancer patients but that the strategy should... Read More
Immunotherapy May Work Better Against Stomach Cancer When Combined with Chemo, Given Earlier
Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of disease and in combination with... Read More
Basilea starts phase 1/2 study FIDES-03 with derazantinib in patients with gastric cancer
Basilea Pharmaceutica has started a study of a drug that inhibits the cancer-driving protein FGFR. It will be studied alone and with... Read More
Association of malnutrition with geriatric assessment impairments and health‐related quality of life among older adults with gastrointestinal malignancies
Gastric cancer patients over age 60 face a high risk of malnutrition, which lowers their quality of life and leads to a... Read More
Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer
Laparoscopic surgery was equally effective as open surgery in gastric cancer patients in extending relapse-free survival periods, a recent study found.
Fluctuating expression of miR-584 in primary and high-grade gastric cancer
A recent study found that H. Pylori infection raises levels of a particular miRNA, which could be used as a biomarker for... Read More
Periodontal Disease, Tooth Loss Linked to Esophageal, Gastric Cancer
Harvard researchers found that people with a history of dental problems also face an increased risk of esophageal and gastric cancer.